These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22676938)

  • 41. Regulation of basal and norepinephrine-induced cAMP and I
    Iqbal Z; Ismaili D; Dolce B; Petersen J; Reichenspurner H; Hansen A; Kirchhof P; Eschenhagen T; Nikolaev VO; Molina CE; Christ T
    Cell Signal; 2021 Jun; 82():109970. PubMed ID: 33677066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats.
    Cheng D; Ren J; Gillespie DG; Mi Z; Jackson EK
    Hypertension; 2010 Dec; 56(6):1096-101. PubMed ID: 20975032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
    Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β
    Rich TC; Leavesley SJ; Brandon AP; Evans CA; Raju SV; Wagener BM
    FASEB J; 2021 Oct; 35(10):e21946. PubMed ID: 34555226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Shakur Y; Fong M; Hensley J; Cone J; Movsesian MA; Kambayashi J; Yoshitake M; Liu Y
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):417-27. PubMed ID: 12652111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β
    Cosson MV; Hiis HG; Moltzau LR; Levy FO; Krobert KA
    J Mol Cell Cardiol; 2019 Jun; 131():132-145. PubMed ID: 31009605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity.
    Lebek S; Plößl A; Baier M; Mustroph J; Tarnowski D; Lücht CM; Schopka S; Flörchinger B; Schmid C; Zausig Y; Pagratis N; Marchand B; Koltun DO; Hung WK; Ahmadyar S; Belardinelli L; Maier LS; Wagner S
    J Mol Cell Cardiol; 2018 May; 118():159-168. PubMed ID: 29614261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
    Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ca(2+)/calmodulin-activated phosphodiesterase 1A is highly expressed in rabbit cardiac sinoatrial nodal cells and regulates pacemaker function.
    Lukyanenko YO; Younes A; Lyashkov AE; Tarasov KV; Riordon DR; Lee J; Sirenko SG; Kobrinsky E; Ziman B; Tarasova YS; Juhaszova M; Sollott SJ; Graham DR; Lakatta EG
    J Mol Cell Cardiol; 2016 Sep; 98():73-82. PubMed ID: 27363295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release.
    Hove-Madsen L; Prat-Vidal C; Llach A; Ciruela F; Casadó V; Lluis C; Bayes-Genis A; Cinca J; Franco R
    Cardiovasc Res; 2006 Nov; 72(2):292-302. PubMed ID: 17014834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.
    Zuo H; Han B; Poppinga WJ; Ringnalda L; Kistemaker LEM; Halayko AJ; Gosens R; Nikolaev VO; Schmidt M
    Br J Pharmacol; 2018 Jul; 175(14):2988-3006. PubMed ID: 29722436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases.
    Ghigo A; Perino A; Mehel H; Zahradníková A; Morello F; Leroy J; Nikolaev VO; Damilano F; Cimino J; De Luca E; Richter W; Westenbroek R; Catterall WA; Zhang J; Yan C; Conti M; Gomez AM; Vandecasteele G; Hirsch E; Fischmeister R
    Circulation; 2012 Oct; 126(17):2073-83. PubMed ID: 23008439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphodiesterase4D (PDE4D)--A risk factor for atrial fibrillation and stroke?
    Jørgensen C; Yasmeen S; Iversen HK; Kruuse C
    J Neurol Sci; 2015 Dec; 359(1-2):266-74. PubMed ID: 26671126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
    Andoh T; Kuraishi Y
    J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.
    Lehnart SE; Wehrens XH; Reiken S; Warrier S; Belevych AE; Harvey RD; Richter W; Jin SL; Conti M; Marks AR
    Cell; 2005 Oct; 123(1):25-35. PubMed ID: 16213210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.